Recent News

• 06.08.2026 - High Prevalence of Endogenous Hypercortisolism in Patients With Type 2 Diabetes and Resistant Hypertension: Results From the MOMENTUM Study
• 06.06.2026 - Effects of Mifepristone in People With Difficult-to-Control T2D and Hypercortisolism on GLP-1 RAs
• 05.30.2026 - SYNERGY: A Phase 1b/2 Study of Nenocorilant, a Selective Glucocorticoid Receptor Antagonist, Plus Nivolumab in Patients With Advanced Solid Malignancies
• 05.30.2026 - TRIDENT: A Phase 2 Study of Relacorilant Plus Nab-paclitaxel and Gemcitabine in Chemotherapy-naïve Patients With Metastatic Pancreatic Ductal Adenocarcinoma
• 05.29.2026 - Overall Survival Subgroup Analyses for Prior Taxane Use in the Phase 3 ROSELLA Trial of Relacorilant Plus Nab-Paclitaxel vs Nab-Paclitaxel Monotherapy in Patients With Platinum-Resistant Ovarian Cancer

Recent Filings

• 06.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 8-K Current report
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2026 - 144 Report of proposed sale of securities
• 06.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.01.2026 - 144 Report of proposed sale of securities